Subsequent researches have shown that glucagon-like peptide-1 infusion improved regional and global left ventricular function in patients with acute myocardial infarction and severe systolic dysfunction after successful primary angioplasty [37]. The gene discussed is GCG; the disease is myocardial infarction.